The Technical Analyst
Select Language :
MiNK Therapeutics, Inc. [INKT]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

MiNK Therapeutics, Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals

MiNK Therapeutics, Inc. is listed at the  Exchange

-0.19% $0.908

America/New_York / 28 mar 2024 @ 16:00


MiNK Therapeutics, Inc.: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 31.52 mill
EPS: -0.650
P/E: -1.400
Earnings Date: May 11, 2024
SharesOutstanding: 34.70 mill
Avg Daily Volume: 0.0533 mill
RATING 2024-03-28
B-
Sell
RATINGS
Rating CashFlow: Neutral
Return On Equity: Strong Buy
Return On Asset: Strong Sell
DE: Sell
P/E: Sell
Price To Book: Strong Sell
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenuen/an/a
Gr.Profit
Ebit
Asset
Debtn/an/an/an/an/an/a
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -1.400 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.24x
Company: PE -1.400 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$0.0980
(-89.21%) $-0.810
Date: 2024-03-28
Expected Trading Range (DAY)

$ 0.841 - 0.975

( +/- 7.38%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-01 Behner Peter Buy 16 185 Common Stock
2024-03-01 Ryan Barbara Buy 18 685 Common Stock
2024-03-01 Wiinberg Ulf Buy 15 790 Common Stock
2024-03-01 Corvese Brian Buy 18 816 Common Stock
2024-01-16 Van Dijk Marcus Antonius Buy 171 078 Stock Option
INSIDER POWER
-44.11
Last 97 transactions
Buy: 6 422 397 | Sell: 29 448 104

Forecast: 16:00 - $0.919

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $0.919
Forecast 2: 16:00 - $0.919
Forecast 3: 16:00 - $0.919
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $0.908 (-0.19% )
Volume 0.0350 mill
Avg. Vol. 0.0533 mill
% of Avg. Vol 65.64 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for MiNK Therapeutics, Inc.

Last 12 Months

Last 12 months chart data with high, low, open and close for MiNK Therapeutics, Inc.

RSI

Intraday RSI14 chart for MiNK Therapeutics, Inc.

Last 10 Buy & Sell Signals For INKT

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            MiNK Therapeutics, Inc.

INKT

MiNK Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. Its product candidate is AGENT-797, an off-the-shelf, allogeneic for iNKT cell therapy and treatment of various myeloma diseases, which is in Phase 1 clinical trials. The company was formerly known as AgenTus Therapeutics, Inc. MiNK Therapeutics, Inc. was incorporated in 2017 and is based in New York, New York. MiNK Therapeutics, Inc. operates as a subsidiary of Agenus Inc.

Last 10 Buy Signals

Date Signal @
LDOUSDMar 29 - 01:252.84
ARKMUSDMar 29 - 01:252.67
APTUSDMar 29 - 01:2517.03
PAXGUSDMar 29 - 01:262 205.00
RLCUSDMar 29 - 01:25$3.95
FILUSDMar 29 - 01:25$9.35
ABTUSDMar 29 - 01:241.981
ALCXUSDMar 29 - 01:19$33.72
HBTCUSDMar 29 - 01:0837 602
ARUSDMar 29 - 01:07$41.90

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.